FHC
DFTX

First Horizon Corporation’s Definium Therapeutics DFTX Stock Holding History

First Horizon Corporation’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
966
+4
+0.4% +$99 ﹤0.01% 719
2026
Q1 		$18.2K Buy
962
+119
+14% +$2.02K ﹤0.01% 916
2025
Q4 		$11.3K Buy
+843
New +$10.4K ﹤0.01% 1089

Other funds holding DFTX

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

First Horizon Corporation's DFTX Position: Q2 2026 in Review

First Horizon Corporation increased its Definium Therapeutics (DFTX) stake by 0.42% in Q2 2026, buying an estimated $99 and bringing the position to 966 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

First Horizon Corporation first reported a position in DFTX in Q4 2025 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • First Horizon Corporation held 966 shares of Definium Therapeutics worth $45.4K as of Q2 2026.
  • First Horizon Corporation bought 4 Definium Therapeutics shares in Q2 2026, an estimated $99.
  • Definium Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #719 holding.
  • First Horizon Corporation first reported a position in Definium Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.